New Therapeutic omega-3 unsaturated fatty acid for nonspecific inflammatory colonic diseases.
用于非特异性炎症性结肠疾病的新型治疗性 omega-3 不饱和脂肪酸。
基本信息
- 批准号:07807125
- 负责人:
- 金额:$ 1.15万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The causes of nonspecific inflammatory diseases of the intestinal tract--Crohn's disease, ulcerative colitis, and intestinal Behcet's disease--are unknown. The remedies for these afflictions are total parenteral nutrition and the administration of steroids and salazosulfa pyridine immunosppressants. It is known, however, that total parenteral nutrition over a long period leads to a decline in local immunocompetence, accompanied by disused atrophy of the intestinal tract. This produces expansion of an auxiliary lesion of the inflammatory diseases and delayd healing.The purposes of the research were as follow ;(1) (a) Preparatory development targeting the creation of an absorbable EPA,which has a superior antiinflammatory effects. (b) The establishment of preparatory technology for emulsification by the use of lecithin, and (c) the creation of an emulsion that includes omega-3 fat by mixing soybean oil and fish oil. (2) Examination of the effectiveness of the pervenous-administration met … More hod, by using the newly developed fat nutrient on diseased-animals' models. (3) Confirmation of the effect as a fat nutrient (a) by administering an appropriate mixture of fish oil to animal models, (b) by analyzing the fatty acid in the serum, and (c) by examining the histological findings and the state of the biological function of the intestinal mucous membranes.The results ;TPN solutions with various fatty acid compositions were administered. Soybean contains 6.9% omega-3 fatty acid and fish oil containns 32.1% of omega-3 fatty acid. The fat emulsions and their relative proportions used in the respective group were as follows :Group I : Soybean oil emulsion only.Group II : mixture of 75% soybean oil and 25% fish oil emulsion.Group III : mixture of 50% soybean oil and 50% fish oil emulsion.Group IV : mixture of 25% soybean oil and 75% fish oil emulsion.Group V : fish oil emulsion only.Group VI : no fat emulsion administered.After completion of the 7-day TPN period the rats were laparotomized under ether anesthesia. The degree of healing of ulcerative colitis was assessed by HE staining of the colitis region and grading in accordance with the criteria.The severity of colitis was least in Group II (containing 13.2% of omega-3 fatty acid), and was relatively greater in Group III,I,IV and VI in that order.Group II displayd a significantly lower degree of severity as compared with group VI according to the Dunnett multiple comparison method and also as compared with group V according to the Tukey multiple comparison method. The result indicates that administration of omega-3 essential fatty acids has an anti-inflammatory effect. Moreover, the results indicated that healing effects could not be expected from administration of fat emulsions containing only soybean oil (Group I).Further studies are necessary in order to ascertain the concentrations between appropriate fish oil dosages. Less
肠道非特异性炎症性疾病——克罗恩病、溃疡性结肠炎和肠道白塞氏病——的病因尚不清楚。已知,这些疾病的治疗方法是全肠外营养和服用类固醇和柳氮磺胺吡啶免疫抑制剂。然而,长期全胃肠外营养会导致局部免疫能力下降,并伴有肠道废弃性萎缩。导致炎症性疾病的辅助病变扩大并延迟愈合。本研究的目的如下;(1)(a)针对创建具有优异抗炎作用的可吸收EPA进行预备开发。建立使用卵磷脂的乳化制备技术,以及(c)通过混合大豆油和鱼油来制备包含omega-3脂肪的乳液(2)有效性检验。通过在患病动物模型上使用新开发的脂肪营养素,证实了静脉给药的效果(a)通过向动物模型施用适当的鱼油混合物,确认了作为脂肪营养素的效果。 (b)通过分析血清中的脂肪酸,以及(c)通过检查组织学结果和肠粘膜的生物功能状态。结果;给予具有各种脂肪酸成分的TPN溶液。大豆含有 6.9% 的 omega-3 脂肪酸,鱼油含有 32.1% 的 omega-3 脂肪酸。各组中使用的脂肪乳剂及其相对比例如下: 第 I 组:仅大豆油乳剂。第 II 组:混合物。 75% 大豆油和 25% 鱼油乳液。第三组:50% 大豆油和50% 鱼油乳剂。IV 组:25% 大豆油和 75% 鱼油乳剂的混合物。V 组:仅鱼油乳剂。VI 组:不施用脂肪乳剂。7 天 TPN 期结束后,将大鼠乙醚麻醉下剖腹手术,通过结肠炎区域HE染色并按照标准分级来评估溃疡性结肠炎的愈合程度。结肠炎在第 II 组中最少(含有 13.2% 的 omega-3 脂肪酸),并且在第 III、I、IV 和 VI 组中依次相对较高。 根据数据,第 II 组的严重程度明显低于第 VI 组与Dunnett多重比较法以及根据Tukey多重比较法与V组相比,结果表明施用omega-3必需脂肪酸具有抗炎作用,并且结果表明愈合效果不明显。可以预料到只含有大豆油的脂肪乳剂(第一组)。为了确定适当的鱼油剂量之间的浓度,有必要进行进一步的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKASAKI Hisao其他文献
NAKASAKI Hisao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKASAKI Hisao', 18)}}的其他基金
Protective Effect of New Enteral Nutritional Formula including Whey Protein Hydrolysate against Indomethacin-Induced Ulceration in Rats
含乳清蛋白水解物的新型肠内营养配方对吲哚美辛引起的大鼠溃疡的保护作用
- 批准号:
11470264 - 财政年份:1999
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
New Therapeutic omega-3 unsaturated fatty acid for nonspecific inflammatory colonic diseases.
用于非特异性炎症性结肠疾病的新型治疗性 omega-3 不饱和脂肪酸。
- 批准号:
05807117 - 财政年份:1993
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Trial of enhancement in lyngbatic organ activety during TPN using PSK
使用 PSK 增强 TPN 期间淋巴器官活性的试验
- 批准号:
03670643 - 财政年份:1991
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Study of The Heterogeneity in Cancer by Monoclonal Antibodies
单克隆抗体对癌症异质性的研究
- 批准号:
63480312 - 财政年份:1988
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
An influence of granulocyte colony-stimulating factor upon pathogenesis of inflammatory bowel disease
粒细胞集落刺激因子对炎症性肠病发病机制的影响
- 批准号:
16591320 - 财政年份:2004
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Role of the Tumor Necrosis Factor Receptor in 2,4,6-Trinitrobenzene Sulphonic Acid (TNBS)-induced Colitis in Mice
肿瘤坏死因子受体在 2,4,6-三硝基苯磺酸 (TNBS) 诱导的小鼠结肠炎中的作用
- 批准号:
15590635 - 财政年份:2003
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Specific CTL Activity of Lamina Propria Lymphocytes in Idiopathic Inflammatory Bowel Diseases.
特发性炎症性肠病中固有层淋巴细胞的特异性 CTL 活性。
- 批准号:
12671217 - 财政年份:2000
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a new therapeutic modality with antisense suppression of MAdCAM-1 gene expression for inflammatory bowel diseases
开发反义抑制 MAdCAM-1 基因表达的炎症性肠病新治疗方式
- 批准号:
11670518 - 财政年份:1999
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The preventive effect of n-butyric acid to TNBS induced rat colitis model
正丁酸对TNBS诱导的大鼠结肠炎模型的预防作用
- 批准号:
08670558 - 财政年份:1996
- 资助金额:
$ 1.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)